BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 12920049)

  • 1. Small, dense HDL particles exert potent protection of atherogenic LDL against oxidative stress.
    Kontush A; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2003 Oct; 23(10):1881-8. PubMed ID: 12920049
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidative activity of HDL particle subspecies is impaired in hyperalphalipoproteinemia: relevance of enzymatic and physicochemical properties.
    Kontush A; de Faria EC; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2004 Mar; 24(3):526-33. PubMed ID: 14739123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential.
    Ribas V; Sánchez-Quesada JL; Antón R; Camacho M; Julve J; Escolà-Gil JC; Vila L; Ordóñez-Llanos J; Blanco-Vaca F
    Circ Res; 2004 Oct; 95(8):789-97. PubMed ID: 15388641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oxidative inactivation of paraoxonase1, an antioxidant protein and its effect on antioxidant action.
    Nguyen SD; Sok DE
    Free Radic Res; 2003 Dec; 37(12):1319-30. PubMed ID: 14753756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL capacity to inhibit LDL oxidation in well-trained triathletes.
    Brites F; Zago V; Verona J; Muzzio ML; Wikinski R; Schreier L
    Life Sci; 2006 May; 78(26):3074-81. PubMed ID: 16488445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients.
    Sanguinetti SM; Brites FD; Fasulo V; Verona J; Elbert A; Wikinski RL; Schreier LE
    Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of oxidative stress and PON1 with LDL and HDL particle size in middle-aged subjects.
    Vekic J; Kotur-Stevuljevic J; Jelic-Ivanovic Z; Spasic S; Spasojevic-Kalimanovska V; Topic A; Zeljkovic A; Stefanovic A; Zunic G
    Eur J Clin Invest; 2007 Sep; 37(9):715-23. PubMed ID: 17696961
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preferential sphingosine-1-phosphate enrichment and sphingomyelin depletion are key features of small dense HDL3 particles: relevance to antiapoptotic and antioxidative activities.
    Kontush A; Therond P; Zerrad A; Couturier M; Négre-Salvayre A; de Souza JA; Chantepie S; Chapman MJ
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1843-9. PubMed ID: 17569880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood pressure-lowering response to amlodipine as a determinant of the antioxidative activity of small, dense HDL3.
    Hansel B; Girerd X; Bonnefont-Rousselot D; Bittar R; Chantepie S; Orsoni A; Bruckert E; Chapman MJ; Kontush A
    Am J Cardiovasc Drugs; 2011 Oct; 11(5):317-25. PubMed ID: 21699274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic syndrome is associated with elevated oxidative stress and dysfunctional dense high-density lipoprotein particles displaying impaired antioxidative activity.
    Hansel B; Giral P; Nobecourt E; Chantepie S; Bruckert E; Chapman MJ; Kontush A
    J Clin Endocrinol Metab; 2004 Oct; 89(10):4963-71. PubMed ID: 15472192
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of 3,4-dihydroxyphenylalanine on Cu(2+)-induced inactivation of HDL-associated paraoxonasel and oxidation of HDL; inactivation of paraoxonasel activity independent of HDL lipid oxidation.
    Nguyen SD; Sok DE
    Free Radic Res; 2004 Sep; 38(9):969-76. PubMed ID: 15621715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiatherogenic function of HDL particle subpopulations: focus on antioxidative activities.
    Kontush A; Chapman MJ
    Curr Opin Lipidol; 2010 Aug; 21(4):312-8. PubMed ID: 20581677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL3-mediated inactivation of LDL-associated phospholipid hydroperoxides is determined by the redox status of apolipoprotein A-I and HDL particle surface lipid rigidity: relevance to inflammation and atherogenesis.
    Zerrad-Saadi A; Therond P; Chantepie S; Couturier M; Rye KA; Chapman MJ; Kontush A
    Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2169-75. PubMed ID: 19762782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
    Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
    Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of paraoxonase 1 of high-density lipoprotein in type 2 diabetic patients with nephropathy.
    Li C; Gu Q
    Nephrology (Carlton); 2009 Aug; 14(5):514-20. PubMed ID: 19207863
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effect of human HDL against Cu(2+)-induced oxidation of astrocytes.
    Ferretti G; Bacchetti T; Moroni C; Vignini A; Curatola G
    J Trace Elem Med Biol; 2003; 17 Suppl 1():25-30. PubMed ID: 14650625
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small, dense high-density lipoprotein 3 particles exhibit defective antioxidative and anti-inflammatory function in familial hypercholesterolemia: Partial correction by low-density lipoprotein apheresis.
    Hussein H; Saheb S; Couturier M; Atassi M; Orsoni A; Carrié A; Therond P; Chantepie S; Robillard P; Bruckert E; Chapman MJ; Kontush A
    J Clin Lipidol; 2016; 10(1):124-33. PubMed ID: 26892129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High density lipoprotein subclasses inhibit low density lipoprotein oxidation.
    Singh K; Chander R; Kapoor NK
    Indian J Biochem Biophys; 1997 Jun; 34(3):313-8. PubMed ID: 9425752
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel lecithin-cholesterol acyltransferase antioxidant activity prevents the formation of oxidized lipids during lipoprotein oxidation.
    Vohl MC; Neville TA; Kumarathasan R; Braschi S; Sparks DL
    Biochemistry; 1999 May; 38(19):5976-81. PubMed ID: 10320323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective antioxidative activity of small dense HDL3 particles in type 2 diabetes: relationship to elevated oxidative stress and hyperglycaemia.
    Nobécourt E; Jacqueminet S; Hansel B; Chantepie S; Grimaldi A; Chapman MJ; Kontush A
    Diabetologia; 2005 Mar; 48(3):529-38. PubMed ID: 15729582
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.